Spatial transcriptomics meets diabetic kidney disease: Illuminating the path to precision medicine

Area of Science:

• Nephrology
• Genomics
• Biotechnology

Background:

• Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease, characterized by kidney tissue remodeling and function loss.
• Single-cell RNA sequencing enhanced understanding of DKD cellular diversity but lacks spatial resolution for microenvironment analysis.
• Spatial transcriptomics (ST) integrates gene expression with spatial localization to dissect tissue-specific molecular mechanisms in DKD.

Purpose of the Study:

• To review the transformative impact of spatial transcriptomics (ST) on diabetic kidney disease (DKD) research.
• To highlight ST's capability in analyzing spatially resolved cell interactions and molecular alterations within the renal microenvironment.
• To discuss the potential of ST in identifying therapeutic targets for DKD.

Main Methods:

• Review of studies utilizing spatial transcriptomics technologies (e.g., Slide-seqV2) in DKD research.
• Analysis of spatially resolved gene expression data to identify localized molecular changes in glomeruli and tubules.
• Integration of ST data with computational tools like machine learning for uncovering gene regulatory networks.

Main Results:

• ST enables detailed analysis of intercellular communication within the renal microenvironment.
• Identified lesion-specific gene expression patterns and immune cell infiltration profiles in DKD.
• Pinpointed key genes, including fibrosis-related proteins and transcription factors, involved in tubular damage.

Conclusions:

• Spatial transcriptomics provides unprecedented insights into the spatial heterogeneity of DKD.
• ST facilitates the discovery of disease-specific cellular neighborhoods and signaling pathways.
• Addressing ST's current limitations in resolution and data complexity is key for advancing precision medicine in DKD.